Focusing on the world of Norwegian Opioid Substitution Treatment (OST) in the aftermath of significant reforms, this book casts a critical light on the intersections between medicine and law, and the ideologies infusing the notions of "individual choice" and "patient involvement" in the field of addiction globally. With ethnographic attention to the encounters between patients, clinicians, and bureaucrats, the volume shows that OST sustains the realities it is meant to address. The chapters follow one particular patient through complex clinical and legal battles as they fight to achieve a better quality of life. The study provides ethnographic insight that captures the individual, experiential aspects of addiction treatment, and how these experiences find a register within different domains of treatment and policy, including the familial, social, legal, and clinical. Offering a rare view of addiction treatment in a Scandinavian welfare state, this book will be of interest to scholars of medical and legal anthropology and sociology, and others with an interest in drug policy and addiction treatment.

EPDF and EPUB available Open Access under CC-BY-NC-ND licence. Human service work is performed in many places – hospitals, shelters, households, prisons, schools, clinics – and is characterised by a complex mixture of organising principles, relations and rules. Using ethnographic methods, researchers can investigate these site-specific complexities, providing multi-dimensional and compelling analyses. Bringing together both theoretical and practical material, this book shows researchers how ethnography can be carried out within human service settings. It provides an invaluable guide on how to apply ethnographic creativeness and offers a more humanistic and context-sensitive approach in the field of health and social care to generating valid knowledge about today’s service work.

A fully revised and updated edition of this unique and authoritative reference The award-winning A Guide to Treatments that Work , published in 1998, was the first book to assemble the numerous advances in both clinical psychology and psychiatry into one accessible volume. It immediately established itself as an indispensable reference for all mental health practitioners. Now in a fully updated edition,A Guide to Treatments that Work, Second Edition brings together, once again, a distinguished group of psychiatrists and clinical psychologists to take stock of which treatments and interventions actually work, which don't, and what still remains beyond the scope of our current knowledge. The new edition has been extensively revised to take account of recent drug developments and advances in psychotherapeutic interventions. Incorporating a wealth of new information, these eminent researchers and clinicians thoroughly review all available outcome data and clinical trials and provide detailed specification of methods and procedures to ensure effective treatment for each major DSM-IV disorder. As an interdisciplinary work that integrates information from both clinical psychology and psychiatry, this new edition will continue to serve as an essential volume for practitioners of every kind: psychiatrists, psychologists, clinical social workers, counselors, and mental health consultants.

"These guidelines were produced by the World Health Organization (WHO), Department of Mental Health and Substance Abuse, in collaboration with the United Nations Office on Drugs and Crime (UNODC) a Guidelines Development Group of technical experts, and in consultation with the International Narcotics Control Board (INCB) secretariat and other WHO departments. WHO also wishes to acknowledge the financial contribution of UNODC and the Joint United Nations Programme on HIV/AIDS (UNAIDS) to this project. " - p. iv

In an effort to make knowledge available about how treatment systems for drug users are organised in different countries, and to facilitate bi- and multilateral co-operation and research, this publication presents an overview of the treatment systems of 22 of the 35 Pompidou Group member countries. In most of Europe, The focus of drug treatment in the 1980s and 1990s was on heroin And The introduction of substitution treatment. However, a shift to cater for polydrug use is now taking place across Europe. The diversity of treatment systems reflects the complexity of the local legal, political, economic and cultural context of drug problems. This source of good practices for making treatment accessible and available will be useful not only for policy makers and practitioners, but also for user groups, researchers And The wider public as well

With a new foreword by Nora Volkow, Director of the National Institute on Drug Abuse, this second edition of Office-Based Buprenorphine Treatment of Opioid Use Disorder provides updated information on evidence-based treatment for opioid use disorder (OUD)-an increasingly important topic as the epidemic of opioid misuse and overdose deaths grows in the United States. Bulleted clinical pearls at the end of each chapter, as well as specific clinical recommendations and detailed case discussions throughout, make it easier for readers to retain knowledge and integrate it into their clinical practice. The guide also features sample documentation and scales, including a treatment contract and a patient consent, that can be used to model documents in practice. This new edition of Office-Based Buprenorphine Treatment has been updated to reflect DSM-5 language, and two additional chapters have been included: one that addresses other pharmacotherapies useful in treating OUD, including methadone and naltrexone, and another that discusses OUD treatment specifically with regard to women's health and pregnancy. A discussion of the Comprehensive Addiction and Recovery Act (CARA). Advice for working with Alcoholics Anonymous and Narcotics Anonymous. A discussion on integrating buprenorphine into residential and inpatient opioid treatment programs. -- Publisher.

Mathilde van den Brink.

Over the past 40 years the rate of illicit drug use worldwide has risen dramatically, and with it the number of deaths reported among drug-using populations. What are the clinical, ethical and psychopathological implications of these deaths? In this book, Shane Darke and his team provide the first full, synthetic review of the epidemiology, causes, prevalence, demography, and associated risk factors of illicit-drug-related mortality. In addition, they examine and evaluate interventions to reduce these deaths. The major causes of death among illicit drug users are overdose, disease, suicide and trauma. Each is independently examined. This is an important book for all clinicians and policy-makers involved in issues relating to illicit drug use.

Ever since the Shanghai convention in 1909, the threat posed to human well-being by drug abuse has led countries around the world to take action to deal with their drug problems. There are wide variations in the policies pursued, but most countries try to reduce both the supply of and the demand for drugs. Unfortunately, there is little research consensus on the respective merits of these two approaches or about the best ways to pursue them. Consequently, control and prevention policies are mostly driven by political considerations, economic realities and cultural expectations, though research has played an important part in formulating and evaluating treatments for drug addiction. This volume reviews studies on drug abuse prevention and treatment strategies under five main areas: 1. Reducing supply - strategies to control the flow of drugs from production to retail distribution; 2. Reducing demand - prevention of drug use at all stages of involvement and consumption levels; 3. Reducing harm - promoting situational risk reduction practices for regular users, addicts and recreational users; 4. Reducing addiction - drug treatment options for various groups in various settings; and 5. Drug policies and prescriptions - focused on debates about prohibition and legalization.

The first volume to provide access to information on drug treatment systems from a wide cross-section of 20 countries, Drug Treatment Systems in an International Perspective examines the ways in which other counties from around the world have chosen to cope with the spread of illicit drugs. Now health planners and administrators, treatment professionals, researchers, and students can place the development of their own treatment systems in a wider context and can examine the extent to which that development shares common structural features with those of other countries and cultures. Following a comparative discussion of the various countries, the volume addresses four key issues: gender specific treatment, the politics of financing and evaluation, the private sector and state control, and exporting drug treatment ideologies. It provides a comparative and cross-cultural perspective on drug treatment approaches today and examines the influence of social, political, and economic forces on the treatment of drug addicts. In addition, the editors have included a handy glossary, which explains key terms unfamiliar to readers outside the particular country. Providing and interdisciplinary and cross-cultural perspective to drug treatment, Drug Treatment Systems in an International Perspective will be of interest academics, students, and professionals in psychology, especially those focusing on clinical psychology, addiction, dependency, and treatment. It will also be of great interest to public health planners and administrators.